Literature DB >> 9034226

Renal disposition of recombinant human interleukin-11 in the isolated perfused rat kidney.

A Takagi1, Y Yabe, Y Oka, K Sawai, Y Takakura, M Hashida.   

Abstract

PURPOSE: To clarify the mechanism of the renal clearance of recombinant human interleukin- 11 (rhIL- 1), we investigated the renal disposition characteristics of rhIL-11 in the perfused rat kidney.
METHODS: The disposition characteristics of (111)In-labeled rhIL-11 were analyzed using a single-pass indicator dilution technique and statistical moment analysis in the perfused rat kidney under filtering and nonfiltering conditions.
RESULTS: Steady-state distribution volume (Vd) calculated from the venous outflow patterns of rhIL-11 at the doses of 0.3 to 10 microg/kidney was between 0.35 and 0.40 ml/g kidney. However, Vd at the highest dose decreased to a value almost identical to that of bovine serum albumin, suggesting that there is a reversible and saturable interaction between the capillary wall and rhIL-11 molecule. In filtering kidney, a remarkable accumulation of rhIL-11 was observed while its urinary excretion was highly restricted at all doses. In nonfiltering kidney, rhIL-11 showed a decreased but still significant renal uptake. Taken together, the marked renal uptake of rhIL-11 may be explained by both efficient tubular reabsorption and significant uptake from the capillary side. These processes were not saturable within the tested dose range. These characteristics of rhIL-11 are likely based on non-specific electrostatic interaction with the tissues due to its cationic charge in the cytokine.
CONCLUSIONS: The renal disposition processes of rhIL-11 were clarified at organ level in a quantitative manner. These findings agree well with previous observations in an in vivo disposition study in mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034226     DOI: 10.1023/a:1012063602856

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

Review 1.  Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.

Authors:  T Maack; V Johnson; S T Kau; J Figueiredo; D Sigulem
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

2.  A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems.

Authors:  T Kakutani; K Yamaoka; M Hashida; H Sezaki
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

3.  Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney.

Authors:  S Hall; M Rowland
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

4.  Renal tubular transport and catabolism of proteins and peptides.

Authors:  F A Carone; D R Peterson; S Oparil; T N Pullman
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

5.  Improved function with amino acids in the isolated perfused kidney.

Authors:  F H Epstein; J T Brosnan; J D Tange; B D Ross
Journal:  Am J Physiol       Date:  1982-09

6.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

7.  Disposition characteristics of protein drugs in the perfused rat kidney.

Authors:  K Mihara; T Hojo; M Fujikawa; Y Takakura; H Sezaki; M Hashida
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

8.  Metabolic activities of the isolated perfused rat kidney.

Authors:  J M Nishiitsutsuji-Uwo; B D Ross; H A Krebs
Journal:  Biochem J       Date:  1967-06       Impact factor: 3.857

9.  The preparation and labeling of DTPA-coupled albumin.

Authors:  D J Hnatowich; W W Layne; R L Childs
Journal:  Int J Appl Radiat Isot       Date:  1982-05

10.  Kidney as a major clearance organ for recombinant human interleukin-1 receptor antagonist.

Authors:  D C Kim; B Reitz; D F Carmichael; D C Bloedow
Journal:  J Pharm Sci       Date:  1995-05       Impact factor: 3.534

View more
  2 in total

1.  Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats.

Authors:  T Uchida; K Aoyama; K Mori; T Usui; T Watanabe; Y Takariki; N Asahara; M Hirose; T Kimura; M Tateishi; S Higuchi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

2.  Daily urinary interleukin-11 excretion correlated with proteinuria in IgA nephropathy and lupus nephritis.

Authors:  Jien-Wen Chien; Woan-Ling Chen; Yi-Giien Tsui; Min-Chun Lee; An-Yi Lin; Ching-Yuang Lin
Journal:  Pediatr Nephrol       Date:  2006-03-10       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.